End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.63 CNY | -5.23% | -15.10% | -51.78% |
Apr. 03 | Chinese Securities Regulator Warns Zhongke Biotechnology Over Late Disclosure of Unit's Suspension | MT |
Apr. 02 | China stocks roughly flat as sentiment remains subdued; HK shares up | RE |
Sales 2021 | 192M 26.55M | Sales 2022 | 681M 94M | Capitalization | 4.63B 639M |
---|---|---|---|---|---|
Net income 2021 | -23M -3.17M | Net income 2022 | -141M -19.46M | EV / Sales 2021 | 55.1 x |
Net Debt 2021 | 1.4B 193M | Net Debt 2022 | 1.38B 190M | EV / Sales 2022 | 8.82 x |
P/E ratio 2021 |
-395
x | P/E ratio 2022 |
-32.7
x | Employees | 908 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 61.58% |
1 day | -5.23% | ||
1 week | -15.10% | ||
Current month | -58.84% | ||
1 month | -55.22% | ||
3 months | -45.85% | ||
6 months | -53.16% | ||
Current year | -51.78% |
Managers | Title | Age | Since |
---|---|---|---|
Rui Chen
CEO | Chief Executive Officer | 51 | 16-08-01 |
Chun Xiang Dong
DFI | Director of Finance/CFO | 37 | 21-07-26 |
Bao Lin Zhang
IRC | Investor Relations Contact | 32 | 20-10-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Cun Zai Han
CHM | Chairman | 59 | 07-07-25 |
Bao Qing Shen Tu
BRD | Director/Board Member | 58 | 23-01-29 |
Rui Chen
CEO | Chief Executive Officer | 51 | 16-08-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.63 | -5.23% | 164,585,200 |
24-04-25 | 1.72 | +4.88% | 148,389,600 |
24-04-24 | 1.64 | -5.20% | 1,988,100 |
24-04-23 | 1.73 | -4.95% | 2,159,400 |
24-04-22 | 1.82 | -5.21% | 261,200 |
End-of-day quote Shanghai S.E., April 25, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-51.78% | 163M | |
+5.14% | 103B | |
-5.63% | 63.04B | |
+39.52% | 39.49B | |
+12.91% | 36.62B | |
+7.41% | 32.44B | |
+6.85% | 19.07B | |
+12.86% | 16.63B | |
+16.93% | 15.14B | |
+7.73% | 14.73B |
- Stock Market
- Equities
- 600165 Stock